Inhaled Treatment Reduces Severe Covid-19 Risk by 79%
An experimental Covid-19 treatment that is delivered directly to the lungs via a nebulizer reduced…
22/07/2020 - 3 minutes
Victor Kotsev
Victor Kotsev is a reporter-at-large. He does all things business, technology, and international politics, with a special focus on health and biotech. He has spent most of the 2010s covering the Balkans and the Middle East for the likes of USA Today, Globe and Mail, and Fast Company, primarily out of Istanbul.
European Biotech Stocks Shine Amid 2020 Market Slump
As the Covid-19 pandemic leads us to the worst financial crisis in decades, normally volatile…
16/07/2020 - 4 minutes
Amryt Makes Nasdaq Debut to Fund Rare Disease Treatments
UK-based biopharmaceutical Amryt Pharma has listed on the Nasdaq Stock Market in a move to…
14/07/2020 - 3 minutes
€18M to Fund First-in-Class Systemic Sclerosis Drug
One of the largest biotech placements in the Nordic countries this year will accelerate the…
09/07/2020 - 2 minutes
Remdesivir Becomes the First Covid-19 Treatment Approved in Europe
Remdesivir has received a one-year conditional marketing authorization from the European Commission due to the…
08/07/2020 - 3 minutes
Pfizer-BioNTech Covid-19 Vaccine Shows Phase I Promise
A vaccine made out of messenger RNA (mRNA), developed by the US pharmaceutical giant Pfizer…
03/07/2020 - 3 minutes
UK Loosens Controls on GW’s Cannabinoid Epilepsy Drug
A cannabinoid medication marketed by GW Pharmaceuticals for the treatment of severe forms of epilepsy…
26/06/2020 - 4 minutes
€30M Series A to Fund Spanish Biotech’s Anti-Metastasis Cancer Drug
A Series A round closed by Barcelona-based startup Ona Therapeutics will finance the preclinical development…
17/06/2020 - 2 minutes
